408 related articles for article (PubMed ID: 37174123)
1. Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.
Sevcikova A; Fridrichova I; Nikolaieva N; Kalinkova L; Omelka R; Martiniakova M; Ciernikova S
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174123
[TBL] [Abstract][Full Text] [Related]
2. A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.
Weiss CN; Ito K
Int Rev Cell Mol Biol; 2017; 334():99-175. PubMed ID: 28838543
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs in diagnosis and prognosis of graft-versus-host disease (GVHD).
Vajari MK; Moradinasab S; Yousefi AM; Bashash D
J Cell Physiol; 2022 Sep; 237(9):3480-3495. PubMed ID: 35842836
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Study of circRNAs in Hematological Malignancies.
Du J; Jia F; Wang L
Front Oncol; 2022; 12():900374. PubMed ID: 35795049
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment.
Nowicki M; Szemraj J; Wierzbowska A; Misiewicz M; Małachowski R; Pluta A; Grzybowska-Izydorczyk O; Robak T; Szmigielska-Kapłon A
Eur J Haematol; 2018 May; 100(5):426-435. PubMed ID: 29380440
[TBL] [Abstract][Full Text] [Related]
8. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: Regulatory Biomarkers in Acute Myeloid Leukemia and Graft Versus Host Disease.
Ramzi M; Shokrgozar N
Clin Lab; 2022 Feb; 68(2):. PubMed ID: 35142182
[TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs in hematological malignancies.
Fatica A; Bozzoni I
Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
[TBL] [Abstract][Full Text] [Related]
11. [The role of microRNAs for immunoregulation after allogeneic hematopoietic cell transplantation].
Stickel N; Zeiser R
Dtsch Med Wochenschr; 2014 Aug; 139(33):1673-8. PubMed ID: 25093955
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
13. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation.
Gaál Z
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628648
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.
Marques SC; Laursen MB; Bødker JS; Kjeldsen MK; Falgreen S; Schmitz A; Bøgsted M; Johnsen HE; Dybkaer K
Oncotarget; 2015 Jan; 6(1):7-25. PubMed ID: 25622103
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic microRNA's in myeloid malignancies.
Khalaj M; Tavakkoli M; Stranahan AW; Park CY
Front Genet; 2014; 5():361. PubMed ID: 25477897
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in benign and malignant hematopoiesis.
Bhagavathi S; Czader M
Arch Pathol Lab Med; 2010 Sep; 134(9):1276-81. PubMed ID: 20807046
[TBL] [Abstract][Full Text] [Related]
17. Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation.
Lim HC; Soneji S; Pálmason R; Lenhoff S; Laurell T; Scheding S
Biomark Res; 2021 Jan; 9(1):6. PubMed ID: 33468257
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance.
Puła A; Robak P; Robak T
Curr Med Chem; 2021 Oct; 28(33):6753-6772. PubMed ID: 33949926
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.
Anelli L; Zagaria A; Specchia G; Musto P; Albano F
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281210
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor.
Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1655-1662. PubMed ID: 32504861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
